Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Mechanism LIV-1 inhibitors(Zinc transporter ZIP6 inhibitors), TOP1 inhibitors(DNA topoisomerase I inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | IND Application | CN | 22 Mar 2024 |